Profil
Dr. Mythili Koneru was previously employed as a Chief Medical Officer by Legend Biotech Corp., a Chief Medical Officer by Marker Therapeutics, Inc., and an Associate Vice President-Immuno-Oncology by Eli Lilly & Co. She received her undergraduate degree from The University of Chicago, a doctorate degree from New York University and a doctorate degree from Robert Wood Johnson Medical School.
Ehemalige bekannte Positionen von Mythili Koneru
| Unternehmen | Position | Ende |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2025 |
| MARKER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.04.2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.02.2019 |
Ausbildung von Mythili Koneru
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
















